Richards, Merrill & Peterson, Inc. Novartis Ag Transaction History
Richards, Merrill & Peterson, Inc.
- $191 Billion
- Q4 2024
A detailed history of Richards, Merrill & Peterson, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Richards, Merrill & Peterson, Inc. holds 172 shares of NVS stock, worth $18,336. This represents 0.01% of its overall portfolio holdings.
Number of Shares
172Holding current value
$18,336% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding NVS
# of Institutions
1,471Shares Held
134MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.3 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.18 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$872 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$732 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$595 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $229B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...